Surprising main obstacle to point-of-care stem cell commercialization by small clinics
There is enormous interest in point-of-care for-profit stem cell commercialization by relatively small clinics hoping to hit it big here in the U.S. Some big investors have poured millions into these clinics that are treating patients with adult stem cell therapies. As I’ve talked with some of these folks they expect this market to grow dramatically […]
Surprising main obstacle to point-of-care stem cell commercialization by small clinics Read More »